NWBO Key Statistics, Chart & Performance
The current stock price of NWBO is 0.57 null. In the past month the price increased by 1.79%. In the past year, price decreased by -87.02%.
NWBO Latest News, Press Relases and Analysis
About NWBO
Company Profile
Northwest Biotherapeutics, Inc. is a biotechnology company focused on discovering, developing, and commercializing immunotherapy products that safely generate and enhance immune system responses to treat cancer.
Company Info
Northwest Bioth New
4800 MONTGOMERY LANE SUITE 800
BETHESDA MD 20814
CEO: Linda F. Powers
Phone: 240-497-9024
Northwest Bioth New / NWBO FAQ
Can you describe the business of Northwest Bioth New?
Northwest Biotherapeutics, Inc. is a biotechnology company focused on discovering, developing, and commercializing immunotherapy products that safely generate and enhance immune system responses to treat cancer.
Can you provide the latest stock price for Northwest Bioth New?
The current stock price of NWBO is 0.57 null. The price decreased by -18.57% in the last trading session.
Does Northwest Bioth New pay dividends?
NWBO does not pay a dividend.
How is the ChartMill rating for Northwest Bioth New?
NWBO has a ChartMill Technical rating of 5 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.
Can you provide the market cap for Northwest Bioth New?
Northwest Bioth New (NWBO) has a market capitalization of 109.33M null. This makes NWBO a Micro Cap stock.
NWBO Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to NWBO. When comparing the yearly performance of all stocks, NWBO is a bad performer in the overall market: 91.35% of all stocks are doing better.
NWBO Financial Highlights
Over the last trailing twelve months NWBO reported a non-GAAP Earnings per Share(EPS) of -0.77. The EPS increased by 32.95% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 100.73% | ||
| ROA | -168.29% | ||
| ROE | 0% | ||
| Debt/Equity | 0 |